Literature DB >> 11166237

The threat of smallpox and bioterrorism.

P Berche1.   

Abstract

Smallpox (variola) was a devastating disease with a high case-fatality rate. Although the disease was eradicated in 1977, the remaining stocks of smallpox virus constitute one of the most dangerous threats to humanity. The smallpox virus is highly specific for humans and non-pathogenic in animals. There is no antiviral treatment and a vaccine is active only if administered in the first four days post-exposure. Smallpox virus represents a potential biological weapon that could be used by terrorists, and the destruction of stocks raises political, social, scientific and ethical issues.

Entities:  

Mesh:

Year:  2001        PMID: 11166237     DOI: 10.1016/s0966-842x(00)01855-2

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  12 in total

1.  Detection of smallpox virus DNA by LightCycler PCR.

Authors:  Mark J Espy; Franklin R Cockerill III; Richard F Meyer; Michael D Bowen; Gregory A Poland; Ted L Hadfield; Thomas F Smith
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

2.  Activities of alkoxyalkyl esters of cidofovir (CDV), cyclic CDV, and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against orthopoxviruses in cell monolayers and in organotypic cultures.

Authors:  Ilya Lebeau; Graciela Andrei; Fabiana Dal Pozzo; James R Beadle; Karl Y Hostetler; Erik De Clercq; Joost van den Oord; Robert Snoeck
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

3.  Antivaccinia activities of acyclic nucleoside phosphonate derivatives in epithelial cells and organotypic cultures.

Authors:  R Snoeck; A Holý; C Dewolf-Peeters; J Van Den Oord; E De Clercq; G Andrei
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

4.  Simultaneous Detection of CDC Category "A" DNA and RNA Bioterrorism Agents by Use of Multiplex PCR & RT-PCR Enzyme Hybridization Assays.

Authors:  Jie He; Andrea J Kraft; Jiang Fan; Meredith Van Dyke; Lihua Wang; Michael E Bose; Marilyn Khanna; Jacob A Metallo; Kelly J Henrickson
Journal:  Viruses       Date:  2009       Impact factor: 5.048

5.  Smallpox and pan-orthopox virus detection by real-time 3'-minor groove binder TaqMan assays on the roche LightCycler and the Cepheid smart Cycler platforms.

Authors:  David A Kulesh; Robert O Baker; Bonnie M Loveless; David Norwood; Susan H Zwiers; Eric Mucker; Chris Hartmann; Rafael Herrera; David Miller; Deanna Christensen; Leonard P Wasieloski; John Huggins; Peter B Jahrling
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

6.  Low-resolution structure of vaccinia virus DNA replication machinery.

Authors:  Céleste Sèle; Frank Gabel; Irina Gutsche; Ivan Ivanov; Wim P Burmeister; Frédéric Iseni; Nicolas Tarbouriech
Journal:  J Virol       Date:  2012-11-21       Impact factor: 5.103

7.  Characterisation of the substrate specificity of homogeneous vaccinia virus uracil-DNA glycosylase.

Authors:  Natale Scaramozzino; Guenhael Sanz; Jean Marc Crance; Murat Saparbaev; Robert Drillien; Jacques Laval; Bodil Kavli; Daniel Garin
Journal:  Nucleic Acids Res       Date:  2003-08-15       Impact factor: 16.971

8.  Smallpox Vaccination of Laboratory Workers at US Variola Testing Sites.

Authors:  Sharon Medcalf; Laura Bilek; Teresa Hartman; Peter C Iwen; Patricia Leuschen; Hannah Miller; Anne O'Keefe; Harlan Sayles; Philip W Smith
Journal:  Emerg Infect Dis       Date:  2015-08       Impact factor: 6.883

9.  Simple technique for in field samples collection in the cases of skin rash illness and subsequent PCR detection of orthopoxviruses and varicella zoster virus.

Authors:  Catherine Dumont; Leonid M Irenge; Edmond K Magazani; Daniel Garin; Jean-Jacques T Muyembe; Mostafa Bentahir; Jean-Luc Gala
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

10.  One time intranasal vaccination with a modified vaccinia Tiantan strain MVTT(ZCI) protects animals against pathogenic viral challenge.

Authors:  Wenbo Yu; Qing Fang; Weijun Zhu; Haibo Wang; Po Tien; Linqi Zhang; Zhiwei Chen
Journal:  Vaccine       Date:  2009-12-30       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.